Clinical Study
Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems
Table 2
Epidemiological characteristics of the cohort.
| | Characteristics | Mean (SD) |
| | Age | 43.4 (14.1) |
| | Characteristics | % (n) |
| | Sex | | | Male | 26.7 (47) | | Female | 73.3 (129) | | Histology | | | Papillary classic subtype | 51.7 (91) | | Papillary follicular subtype | 26.1 (46) | | Follicular | 12.5 (22) | | Poorly differentiated/insular | 2.8 (5) | | Hurthle cell | 1.1 (2) | | Mixed histology | 4 (7) | | Papillary oncocytic subtype | 1.7 (3) | | ETA risk stratification | | | Low | 56.3 (99) | | High | 43.7 (77) | | ATA risk stratification | | | Low | 55.7 (98) | | Intermediate | 39.8 (70) | | High | 4.5 (8) | | RIT risk stratification | | | Excellent | 72.7 (128) | | Acceptable | 10.8 (19) | | Incomplete | 16.5 (29) | | Evidence of disease at final follow-up | | | No evidence of disease after initial therapy | 72.2 (127) | | No evidence of disease after additional therapy | 6.8 (12) | | Persistent biochemical disease | 14.2 (25) | | Persistent structural disease | 5.7 (10) | | Disease specific mortality | 1.1 (2) |
|
|
n = 176; SD: standard deviation.
|
